rs143603619

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The ENST00000299698.12(A2ML1):​c.3550A>T​(p.Ser1184Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00076 in 1,614,240 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 4 hom., cov: 34)
Exomes 𝑓: 0.00044 ( 5 hom. )

Consequence

A2ML1
ENST00000299698.12 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.155
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00532642).
BP6
Variant 12-8863841-A-T is Benign according to our data. Variant chr12-8863841-A-T is described in ClinVar as [Benign]. Clinvar id is 413823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 585 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
A2ML1NM_144670.6 linkuse as main transcriptc.3550A>T p.Ser1184Cys missense_variant 29/36 ENST00000299698.12 NP_653271.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
A2ML1ENST00000299698.12 linkuse as main transcriptc.3550A>T p.Ser1184Cys missense_variant 29/361 NM_144670.6 ENSP00000299698 P1A8K2U0-1
ENST00000631830.1 linkuse as main transcriptn.322-5565T>A intron_variant, non_coding_transcript_variant 3
A2ML1ENST00000541459.5 linkuse as main transcriptc.2200A>T p.Ser734Cys missense_variant 18/252 ENSP00000443174
A2ML1ENST00000539547.5 linkuse as main transcriptc.2077A>T p.Ser693Cys missense_variant 18/252 ENSP00000438292 A8K2U0-2

Frequencies

GnomAD3 genomes
AF:
0.00384
AC:
585
AN:
152246
Hom.:
4
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0136
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00103
AC:
256
AN:
249514
Hom.:
3
AF XY:
0.000761
AC XY:
103
AN XY:
135374
show subpopulations
Gnomad AFR exome
AF:
0.0149
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000530
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000439
AC:
642
AN:
1461876
Hom.:
5
Cov.:
29
AF XY:
0.000371
AC XY:
270
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.0151
Gnomad4 AMR exome
AF:
0.000738
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000486
Gnomad4 OTH exome
AF:
0.000778
GnomAD4 genome
AF:
0.00384
AC:
585
AN:
152364
Hom.:
4
Cov.:
34
AF XY:
0.00370
AC XY:
276
AN XY:
74508
show subpopulations
Gnomad4 AFR
AF:
0.0136
Gnomad4 AMR
AF:
0.00105
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000591
Hom.:
0
Bravo
AF:
0.00453
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00991
AC:
38
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00114
AC:
138
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 22, 2019Variant summary: A2ML1 c.3550A>T (p.Ser1184Cys) results in a non-conservative amino acid change located in the Alpha-macroglobulin-like, TED domain (IPR011626) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0013 in 280918 control chromosomes, predominantly at a frequency of 0.014 within the African or African-American subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3500 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome and Related Conditions phenotype (4e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.3550A>T in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submissions (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 15, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 18, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
18
DANN
Uncertain
0.97
DEOGEN2
Benign
0.042
T;T;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.69
T;T;T
MetaRNN
Benign
0.0053
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.9
L;.;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-2.6
D;N;N
REVEL
Benign
0.043
Sift
Benign
0.062
T;T;T
Sift4G
Benign
0.075
T;T;T
Polyphen
1.0
D;.;.
Vest4
0.21
MVP
0.081
MPC
0.48
ClinPred
0.051
T
GERP RS
-3.3
Varity_R
0.057
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143603619; hg19: chr12-9016437; API